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Objective. The purpose of this study was to elucidate the impact of the clinical presentation on perinatal outcome in placental
abruption. Study Design. A retrospective study was performed in 97 placental abruptions. Placental abruptions were classiﬁed
according to clinical presentation: pregnancy-induced hypertension (HT, n = 22), threatened premature labor and/or premature
rupture of membranes (TPL/ROM, n = 35), clinically low risk (LR, n = 27), and others (n = 13). Perinatal outcomes were
compared among the HT, TPL/ROM, and LR groups. Results. The HT had signiﬁcantly higher incidence of IUGR, IFUD, and low
ﬁbrinogen. The TPL/ROM had less severe disease. However, the LR had signiﬁcantly higher incidence of IUFD, low UA pH < 7.1,
l o wA p g a rs c o r eo f<7 at 5min, and low ﬁbrinogen. Conclusion. Disease severity in placental abruption is likely to depend on the
clinical presentation.
1.Introduction
Placental abruption is a major cause of poor perinatal
outcome [1–3] and occurs in approximately 1% of all
pregnancies [4, 5]. In order to elucidate the etiology of
placental abruption, maternal risk factors and episodes of
placental abruption need to be evaluated. To date, at least
2 major pathways have been proposed to account for pla-
cental abruption: (1) inﬂammation-associated processes and
(2) ischemia-associated process [6]. For example, women
presenting with preterm premature rupture of membranes
(preterm PROM) are at increased risk of developing abrup-
tion, and histologic chorioamnionitis is associated with
placental abruption [7, 8]. Poor trophoblast invasion to
decidua accounts for the etiology of placental abruption
[9, 10], and it is now agreed that placental abruption occurs
with increasing frequency in patients with chronic hyper-
tension [11]. Thus, preterm PROM, threatened premature
labor, and hypertension are major risk factors correlated
with placental abruption, although placental abruption also
occurs in women without the known risk factors. Although
the frequency of placental abruption is higher in women
with preterm PROM or pregnancy-induced hypertension, it
is unknown if the severity of placental abruption increases in
such cases.
Attempts have been made to correlate the perinatal
outcome of placental abruption with single risk factors such
as prematurity, hypertension, inﬂammation, and multiple
pregnancy [12–15]. In these studies, coexisting risk factors
that may contribute to the development of placental abrup-
tion were not excluded and therefore may have led to a mis-
interpretation of the results. Furthermore, only a few reports
have compared perinatal outcome in placental abruption
among groups having diﬀerent clinical presentations such
as genital bleeding and female gender of the fetus [16, 17].
Therefore, we compared the perinatal outcome of placental
abruption among diﬀerent clinical presentations.
2.MaterialsandMethods
We retrospectively reviewed medical charts of women with
placental abruption that were admitted to the Perinatal2 Journal of Pregnancy
Center of the University of Miyazaki and Miyazaki Medical
Association Hospital from January 1997 to April 2009.
University of Miyazaki is a tertiary-level center and Miyazaki
Medical Association Hospital is a secondary-level hospital.
In our area, 80% of pregnant women give birth at a
private clinic. Both centers mainly dealt with referral cases
from private clinics, and the total number of deliveries
was 8557. In this study, we determined placental abruption
by the presence of retroplacental hematoma and clinical
presentations (any one or combination of genital bleeding,
abdominal pain, pregnancy-induced hypertension, prema-
ture labor, premature rupture of membrane, intrauterine
fetal death, or non-reassuring fetal heart rate pattern).
Conﬁrmation of retroplacental hematoma was made by
visual examination after delivery. If hematoma was evident
immediately after detachment of the placenta, this was
also regarded as retroplacental hematoma. If clotting was
incidentally founded in the absence of any clinical signs, the
casewasexcluded.Casesinvolvingmultiplepregnancieswere
also excluded. Finally, a total of 97 pregnancies displaying
placental abruption were included.
In this study, chronic hypertension was deﬁned as hyper-
tension diagnosed prior to conception or within the ﬁrst 20
weeks of pregnancy. Pregnancy-induced hypertension such
as gestational hypertension, preeclampsia, eclampsia, and
superimposed preeclampsia was deﬁned according to the
classiﬁcation of National High Blood Pressure Education
Program Working Group Report on High Blood Pressure in
Pregnancy [18]. Women with pregnancy-induced hyperten-
sionweremanagedwithmaternalbloodpressuremonitoring
(3∼4times/day), weekly renal and liver function tests, daily
fetal heart rate monitoring (FHR monitoring), daily fetal
movement count, weekly biophysical proﬁle scoring (BPS),
and weekly fetal biometry using ultrasonography (USG).
Pregnancy was terminated in severe cases such as those
involving persistent severe hypertension (blood pressure >
160/110mmHg), oliguria (<500mL/day), low platelet count
(<100,000/mm3), HELLP syndrome (hemolysis, elevated
liver enzyme and low platelets), pulmonary edema, or
eclampsia. The severity of proteinuria alone was not an
indication to terminate pregnancy [19]. Pregnancies were
also terminated if there was any evidence of apparent
intrauterine growth restriction (IUGR) or non-reassuring
fetal heart rate patterns (NRFHR).
Threatened premature labor (TPL) was deﬁned when the
patient had uterine contractions of four in 20 minutes or
eight in 60 minutes with progressive changes of dilatation
and/oreﬀacementinthecervix.Tocolysiswasﬁrstconducted
with continuous intravenous administration of ritodrine
hydrochloride. The FHR monitoring was also conducted to
detect potential fetal hypoxia prior to the start of tocolysis.
Tocolysis was stopped if fetal asphyxia was evident. If uterine
contractions continued, magnesium sulfate was added.
W ed e ﬁ n e dN R F H Ra n dl o wB P S( ≤4) as fetal
asphyxia. Non-reassuring FHR patterns to terminate preg-
nancy included recurrent late decelerations, recurrent severe
variable decelerations, or prolonged deceleration.
Ninety-seven placental abruptions were then classiﬁed
into 4 subgroups according to the clinical presentation.
Women with pregnancy-induced hypertension who had
chronic hypertension were categorized as HT (n = 22).
Women with threatened premature labor and/or premature
rupture of membrane (ROM) were categorized as TPL/ROM
(n = 35). Women that had other medical or obstetrical
risk factors were categorized as others (n = 13). Women
without the aforementioned risk factors were categorized
as clinically low risk (LR, n = 27). Women with HT and
ROM were regarded as HT. Women admitted to hospital
with genital bleeding, abdominal pain, or loss of fetal
movement were distinguished from TPL if NRFHR was also
diagnosed at admission. Perinatal outcomes were compared
among the HT, TPL/ROM, and LR groups. Since others
(n = 13) had heterogeneous risk factors (Table 1), we
omitted them from this study. Thus, this study focused
on assigning inﬂammation-associated processes, ischemia-
associated processes, and low risk.
The following clinical characteristics were collected:
maternal age, primipara, gestational age at delivery (weeks),
birth weight (g), presence of genital bleeding for ﬁrst
awareness, and medical complications such as diabetes
mellitus and thyroid disease. Perinatal outcomes including
the incidence of ﬁbrinogen at <150mg/dl, platelet count
<10 × 104/mm3, cesarean delivery, intrauterine fetal death
(IUFD), IUGR, umbilical artery pH < 7.1 (UA pH < 7.1),
and an Apgar score of <7a t5m i n u t e sw e r ea l s oe v a l u a t e d .
The ﬁbrinogen and platelet count values of the mother were
obtained at the time of diagnosis of placental abruption.
IUGR was deﬁned as sex-speciﬁc birth weight less than the
10th percentile for gestational age according to the Japanese
standard growth curve for singleton.
We also obtained the pathological ﬁndings of pla-
centas for clinical classiﬁcation. The following ﬁndings
were obtained for each placenta: chorioamnionitis, ischemic
changes, and infarcts. Ischemic changes included chorangio-
sis, increased syncytial knots, and atherosis of uteroplacental
vessels. Necrosis of the decidual tissue and angioectasia,
and ﬁbrinoid degeneration of the villi were excluded from
consideration as ischemic changes.
Comparisons among groups were made using the one-
way ANOVA or χ2 tests. Post hoc analysis was performed
using the Bonferroni-Dunn test.
3. Results
As shown in Table 2, the incidence of primipara was not
signiﬁcant. TPL/ROM was marked by early gestational age
compared to HT and LR (P<. 01 and P<. 01). However,
there was no signiﬁcant diﬀerence in birth weight among the
groups. The presence of genital bleeding for ﬁrst awareness
was higher in the TPL/ROM group (P = .03 versus HT);
however, no diﬀerence was observed between the HT and LR
groups (P = .35).
There was a signiﬁcant diﬀerence in the incidence of
IUGR, IUFD, UA pH < 7.1, and ﬁbrinogen at <150mg/dl
(Table 3). The HT group had signiﬁcantly higher incidence
of IUGR, IFUD, and low ﬁbrinogen. The TPL/ROM group
did not have any particular trends in risk factors. However,
LR group had signiﬁcantly higher incidence of IUFD, lowJournal of Pregnancy 3
Table 1: Medical and obstetrical complications in the others group.
Number 13
Perinatal outcome
IUFD UA pH < 7.1
among live births
Fibrinogen < 150mg/dl
Medical complications
Asthma 1 1 1
Chronic nephritis 1
Smoker (>1p a c kp e rd a y ) 2 1 1 2
Obstetrical complications
Prior cesarean section 3 1 1 1
Prior placental abruption 2 (1: prior cesarean section) 2 1
IUGR without HT and oligohydramnios 1
Oligohydramnios without HT and ROM 3 2
IUGR: intrauterine growth restriction, HT: pregnancy induced hypertension, and ROM: premature rupture of membrane.
Table 2: Demographic data of women complicated with placental
abruptionamongtheHT,TPL/ROM,andclinicallylowriskgroups.
HT TPL/ROM Clinically low risk
Number 22 35 27
Age (yr) 31.4 ± 6.5† 27.9 ± 5.2 28.4 ± 4.1
Nulliparity (%) 13 (59%) 19 (54%) 11 (41%)
Gestational age at
delivery (wk)
34.2 ± 4.0† 31.3 ± 4.4 34.4 ± 3.4†
Birth weight (g) 2097 ± 747 1767 ± 704 2200 ± 548
Genital bleeding for
the ﬁrst symptom
2∗ 12 5
Medical
complication
DM 10 0
Thyroid disease 30 0
R e s u l t sa r ee x p r e s s e da sM e a n± SD or incidence (%). HT: pregnancy-
induced hypertension, TPL/ROM: threatened premature labor and/or
premature rupture of membrane, and DM: diabetes mellitus.
∗P <. 05 versus TPL/ROM by χ2 test. †P <. 05 versus TPL/ROM by
Bonferroni/Dunn analysis.
UA pH < 7.1, low Apgar score of <7a t5m i n u t e s ,a n dl o w
ﬁbrinogen.
According to the histological ﬁndings, chorioamnionitis
was most marked in the TPL/ROM group compared to HT
and LR (P = .02 and P = .03, Table 4). The incidence of
ischemic changes in the HT group was higher compared to
the LR group (P = .03). The incidence of infarcts in LR was
higher compared to TPL/ROM (P<. 01).
4. Discussion
In this study, we demonstrated a signiﬁcant diﬀerence
in perinatal outcome among the HT, TPL/ROM, and LR
groups. Surprisingly, clinically low risk women were most
likely to have more severe manifestation including a high
incidence of IFUD, ﬁbrinogen at <150mg/dl, UA pH <7.1,
and a low Apgar score. The HT group also had a high
incidence of IUFD and ﬁbrinogen at <150mg/dl, although
theincidenceoflowpHandalowApgarscorewaslowerthan
that of LR. The TPL/ROM group was marked by the lowest
incidence of severe disease among the 3 groups. We showed
here the relationship between clinical presentation of women
and perinatal outcome with respect to placental abruption.
We divided a group of women with placental abruption
into four groups, that is, HT, TPL/ROM, clinically low
risk, and others, according to the clinical presentations. We
determined the clinical classiﬁcation based on the etiology
of placental abruption. To date, at least 2 major pathways
have been proposed to account for placental abruption,
inﬂammation- and ischemia-associated processes [6]. It has
been reported that poor trophoblast invasion to decidua
accounts for the etiology of placental abruption [9, 10], and
the pathological ﬁndings of placentas are common to both
placental abruption and pregnancy-induced hypertension
[11]. Thus, we regarded pregnancy-induced hypertension
and chronic hypertension as belonging to the ischemic
process. In terms of inﬂammatory processes, it has been
reported that women presenting with preterm PROM are
at increased risk of developing abruption [7]. Nath et
al. reported that histologic chorioamnionitis is associated
with placental abruption [8]. Thus, we regarded premature
rupture of the membrane and premature labor as belonging
to inﬂammation-associated processes. Since the risk factors
were not uniform in other group, this was omitted from this
study. This study focused on assigning inﬂammation- and
ischemia-associated processes. To validate our classiﬁcation,
placentas were checked for pathological lesions. Consistent
with the histological records, chorioamnionitis was most
noted in the TPL/ROM group compared to the HT and LR
groups. In addition, the incidence of ischemic changes in the
HT group was higher compared to the LR group. As a result,
ourclinicalclassiﬁcationwasshown tobeconsistentwiththe
histological examinations.
We previously reported perinatal outcomes in low risk
pregnancies over 32 weeks’ of gestation [20]. We found 9
children with cerebral palsy (CP) out of 5522 low risk preg-
nancies. Among these, two were cytomegalovirus infection,
one was amniotic ﬂuid embolism during labor, and the other
6 were placental abruption. These 6 women with placental4 Journal of Pregnancy
Table 3: The perinatal outcome of women complicated with placental abruption among groups of HT, TPL/ROM, and clinically low risk.
HT TPL/ROM Clinically low risk
Number 22 35 27
Cesarean delivery (%) 16 (73%) 27 (77%) 23 (85%)
IUGR (%) 10 (45%)∗ 2 (6%) 4 (15%)
IUFD (%) 6 (27%)∗ 0 (0%) 7 (26%)∗
UA pH < 7.1 among live births (%) 3 (19%) 2 (6%) 11 (55%)∗†
Low Apgar score at 5 min (less than 7) among live births (%) 1 (6%) 4 (11%) 10 (50%)∗†
Fibrinogen < 150mg/dl 6 (27%)∗ 0 (0%) 10 (37%)∗
Platelet count < 10 × 104/mm3 3 (14%) 1 (3%) 1 (4%)
Results are expressed as Mean ± SD or incidence (%). HT: pregnancy-induced hypertension and TPL/ROM: threatened premature labor and/or premature
rupture of membrane.
∗P <. 05 versus TPL/ROM by χ2 test. †P <. 05 versus HT by χ2 test.
Table 4: The histological study of women complicated with
placental abruption among groups of HT, TPL/ROM, and clinically
low risk.
HT TPL/ROM Clinically low risk
Number 22 35 27
(No histological records) (6) (4) (3)
Chorioamnionitis (%) 1 (6%)∗ 12 (39%) 3 (13%)∗
Ischemic changes (%) 7 (44%) 7 (23%) 3 (13%)†
Infarcts (%) 5 (31%) 3 (10%) 10 (42%)∗
R e s u l t sa r ee x p r e s s e da sM e a n± SD or incidence (%). HT: pregnancy-
induced hypertension and TPL/ROM: threatened premature labor and/or
premature rupture of membrane.
∗P <. 05 versus TPL/ROM by χ2 test. †P <. 05 versus HT by χ2 test.
abruption showed non-reassuring fetal heart rate patterns
on admission. On the other hand, 81 women developed
placental abruption after hospitalization, and there were no
cases of children who developed CP. Since women with
high risk factors such as hypertension, endocrine disorders
or multiple pregnancies were excluded, 81 women were
hospitalized due only to TPL. Our study also showed the
TPL/ROM group was marked by the lowest incidence of
severe disease. On the other hand, the HT and clinically low
risk groups were marked by severe disease. Thus, perinatal
outcome of placental abruption is associated with clinical
presentation of the mother during pregnancy.
In terms of perinatal outcome of placental abruption,
Morgan et al. showed that no overall diﬀerence in perinatal
outcome was observed between groups with or without
hypertension [13]. This is partially consistent with our
results. In our study, although maternal morbidity in HT
was similar to the low risk group, the low risk women
experiencing placental abruption were more likely to have
low UA pH and low Apgar scores. This diﬀerence is partially
due to nonhospitalization, as the low risk women were
not hospitalized, leading to delayed care. We also found
that clinically low risk women showed higher incidence
of ﬁbrinogen consumption. In addition, clinically low risk
women more likely have “concealed hemorrhage”, since the
presence of genital bleeding for ﬁrst awareness was fewer in
the HT and LR groups compared to the TPL/ROM group.
This is not only due to consumptive coagulopathy, but also
due to the fact that the extent of hemorrhage is not readily
discovered and the diagnosis is delayed [21]. However, an
explanation as to why clinically low risk women without
ischemia or inﬂammation were likely to have severe disease
could not be clearly ascertained in this study. Unknown fac-
tors independent of ischemia and inﬂammation may operate
in the development of placental abruption. Interestingly,
we observed that clinically low risk women had infarcts in
placentas without ischemic changes although infarcts were
reported less prominent in women without hypertension
[22]. Thus, a new pathway leading to placental abruption
may be associated with the etiology of placental infarction.
Further studies are required to elucidate the mechanisms
leading to placental abruption in the absence of ischemia or
inﬂammation.
In conclusion, we showed the relationship between some
clinical presentations and poor outcome in women with
placental abruption. Clinically low risk women have similar
risk to have poor outcome compared to the HT group. The
TPL/ROM group had the least severe disease among the 3
groups. In a clinical situation, opportunities exist for early
recognition and prompt deliveries in cases where the mother
has a clinical presentation of hypertension, TPL, or ROM.
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